For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the PancreasTanaka M.a · Chari S.b · Adsay V.c · Fernandez-del Castillo C.d · Falconi M.e · Shimizu M.f · Yamaguchi K.a · Yamao K.g · Matsuno S.h
aDepartment of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; bDepartment of Gastroenterology, Mayo Clinic, Rochester, Minn., USA; cDepartment of Pathology, Wayne State University and The Karmanos Cancer Center, Harper Hospital, Detroit, Mich., USA; dDepartment of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Mass., USA; eDepartment of Surgery, Verona University, Verona, Italy; fDepartment of Pathology, Saitama Medical School, Saitama, Japan; gDepartment of Gastroenterology, Aichi Cancer Center, Nagoya, Japan, and hDepartment of Gastroenterological Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan Corresponding Author
Masao Tanaka, MD, PhD, FACS
Department of Surgery and Oncology
Graduate School of Medical Sciences, Kyushu University
Fukuoka 812-8582 (Japan)
Tel. +81 92 642 5437, Fax +81 92 642 5457, E-Mail email@example.com
Non-inflammatory cystic lesions of the pancreas are increasingly recognized. Two distinct entities have been defined, i.e., intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN). Ovarian-type stroma has been proposed as a requisite to distinguish MCN from IPMN. Some other distinct features to characterize IPMN and MCN have been identified, but there remain ambiguities between the two diseases. In view of the increasing frequency with which these neoplasms are being diagnosed worldwide, it would be helpful for physicians managing patients with cystic neoplasms of the pancreas to have guidelines for the diagnosis and treatment of IPMN and MCN. The proposed guidelines represent a consensus of the working group of the International Association of Pancreatology.
© 2006 S. Karger AG, Basel and IAP